GL1X · GenesisL1 explorer

MolNFT v1 · #122746 · protein

Protruding domain of GII.4 human norovirus CHDC2094 in complex with hbga type B (triglycan)

5IYQ · Protruding domain of GII.4 norovirus CHDC2094 capsid: “Protruding domain of GII.4 human norovirus CHDC2094 in complex with hbga type B (triglycan)”. X-ray diffraction, 2 ligands (GLA, FUC), 7 pockets (best druggability 0.70). MolNFT…

PDB
5IYQ
Type
protein
Length
608 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protruding domain of GII.4 norovirus CHDC2094 capsid
UniProt
D0QJ68
Ligands
GLA, FUC
Pockets
7 · best druggability 0.70

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtruding domain of GII.4 norovirus CHDC2094 capsidprotein3037% helix, 35% strandD0QJ68
BProtruding domain of GII.4 norovirus CHDC2094 capsidprotein3057% helix, 36% strandD0QJ68

Ligands and binding sites

  • GLA · alpha-D-galactopyranose · sugar · 4 copies · chains B, A
  • FUC · alpha-L-fucopyranose · sugar · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 12 copies · chains A, B
  • FLC · Citrate anion · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1510.700.9821empty
21880.660.8635EDO
32580.640.8231empty
42390.600.8029EDO
51840.560.8029empty

Interfaces

1 interface between chains.

  • A–B · 1915 Ų buried · 25 hydrogen bonds · protein-protein

Compared structures

  • 5IYQ · Protruding domain of GII.4 human norovirus CHDC2094 in complex with HBGA type B… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.